Pericarditis aguda

  1. Martínez Monzonís, A. 1
  2. Otero García, O. 1
  3. Abou Johk, C. 1
  4. García Campos, A. 1
  5. González Juanetey, J.R. 1
  1. 1 Servicio de Cardiología. Hospital Clínico de Santiago de Compostela. Santiago de Compostela. La Coruña. España. CIBERCV
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2021

Issue Title: Enfermedades cardiovasculares (IX)

Series: 13

Issue: 43

Pages: 2495-2507

Type: Article

DOI: 10.1016/J.MED.2021.10.001 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Acute pericarditis (AP) is defined as a set of symptoms and signs that are the consequence of acute inflammation of the pericardium. Although it is the most frequent pericardial disease, its incidence and prevalence are difficult to determine, given that it tends to be infradiagnosed and thus the real incidence of this pathology is unknown. The most frequent cause of pericarditis is idiopathic, although in many cases this diagnosis is reached because a suitable search for its origin is not conducted, especially in regard to infections. Clinical, semiological, and cardiac imaging data are required to make a diagnosis. Although the echocardiography is the first-choice imaging technique for diagnosis, appropriate use of multimodal imaging allows for better characterization of patients. In recent years, treatment has undergone important changes, with colchicine being added to the non-steroidal anti-inflammatory drugs used as first-line therapy. Seventy percent to 90% of patients with AP have a good short-term prognosis without significant complications and clinical symptoms resolving in a few weeks. However, up to 15% have associated myocarditis and 1.8% progress with constrictive pericarditis.

Bibliographic References

  • Le Winter MM, Tischler MD. Enfermedades pericárdicas. En: Bonow RO, Man DL, Zipes DP, Libby P, Braunwald D, eds. Brunwald tratado de cardiología texto de medicina cardiovascular. 9ª ed. Barcelona: Elsevier; 2013. p. 1673-94.
  • Frick H, Leonhardt H, Stark D. Corazón y pericardio. En: Frick H, Leonhardt H, Stark D, eds. Manual de anatomía humana II. 1ª ed. Barcelona: Ediciones Omega; 1981. p. 268-95.
  • Munt B, Moss RR, Thomson ChR. Pericardial disease. En: Otto CM, ed. The practice of clinical echocardiography. 5ª ed. Philadel-phia: Saunders Elsevier; 2016. p. 710-34.
  • Adler Y, Charron P, Imazio M, Badano L, Barón Esquivias G, Bogaert J. ESC Scientific Document Group. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Disea-ses of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-64.
  • Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004 Feb 28;363(9410):717-27.
  • Chiabrando JG, Bonaventura A, Vecchié A, Wohlford GF, Mauro AG, Jordan JH. Manegement of acute and recurrent pericarditis: JACC State of the Art Review. J Am Coll Cardiol. 2020;75:76-92.
  • Chetrit M, Xu B, Kwon DH, Ramchand J, Rodriguez RE, Tan CD. Imaging guided therapies for pericardial diseases. JACC State of the Art Review. J Am Coll Cardiol Imag. 2019;13:1422-37.
  • LeWinter MM. Acute pericarditis. N Engl J Med. 2014;371: 2410-6.
  • Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review. JAMA. 2015;314(14):1498-506.
  • Kytö V, SipiläJ, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014;130:1601-6.
  • Pankuweit S, Ristic AD, Seferovic PM, Maisch B. Bacterial pericarditis Diagnosis and Manegement. Am J Cardiovas Drugs. 2005;5: 103-12.
  • Imazio MI, Brucato A, Maestroni S, Cumetti D, Dominelli A, Natale G. Prevalence of C-reactive protein elevation and time course of normalization in acute perivarditis. Implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011; 123:1092-97.
  • Leitman M, Bachner Hinenzon N, Adam D, Fuchs T, Theodorovich N, Peleg E. pecle tracking imaging in acute inflamatory pericardial diseases. Echocardiography. 2011;28:548-55.
  • Cremer PC, Kumar A, Kontzias A, Tan CD, Rodríguez ER, Imazio M. Complicated pericarditis understanding risk factors and pathophysiology to inform imaging treatment. Focus seminar: Pericardial and myocardial disease. J Am Coll Cardiol. 2016;68:2311-28.
  • Treglia G, Radichtkova M, Ceriani L, Giovanella L. A “ring of fire” around the heart: pericarditis detected by FDG-PET/CT. Médecine Cardiovasculaire. 2018;21:234-5.
  • Hyeon CW, Yi HK, Kim EK, Park SJ, Lee SC, Park SW. The role of 18F-fluorodeoxiglucose-positron emision tomography/computed tomography in the differential diagnosis of pericardial disea-se. Sci Rep. 2020;10(1):21524.
  • Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S. ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disea-se. Eur Heart J. 2021 Jan 1;42(1):17-96.
  • Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522-8.
  • Lutschinger LL, Rigopoulos AG, Schlattmann P, Matiakis M, Sedding D, Schulze PC. Meta analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syn-drome. BMC Cardiovasc Disord. 2019;19(1):207.
  • Sambola A, Roca Luque I, Mercé J, Alguersuari J, Francisco Pascual J, García Dorado D. Colchicine administered in the first episode of acute idiopathic pericarditis: A randomized multicenter open-label study. Rev Esp Cardiol (Engl Ed). 2019;72(9):709-16.
Data source: Dialnet